The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1244
ISSUE1244
September 25, 2006
A Once-Daily Combination Tablet (Atripla) for HIV
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A Once-Daily Combination Tablet (Atripla) for HIV
September 25, 2006 (Issue: 1244)
Atripla (Gilead/Bristol-Myers Squibb) is the first once daily, single-tablet combination of 3 antiretroviral drugs for treatment of HIV infection. Each tablet contains 600 mg of the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.